C-Reveal Therapeutics develops drugs that reveal hidden cancer cells so the immune system can detect and destroy them more effectively.
C-Reveal Therapeutics has raised $1.0M in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in February 2022.
C-Reveal Therapeutics is headquartered in San Mateo, United States.
C-Reveal Therapeutics develops drugs that reveal hidden cancer cells so the immune system can detect and destroy them more effectively.
C-Reveal Therapeutics is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"C-Reveal Therapeutics — Funding & Investors." VCBacked, February 8, 2022, https://www.vcbacked.co/company/c-reveal-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). C-Reveal Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/c-reveal-therapeutics
{{cite web |title=C-Reveal Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/c-reveal-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated